Author

L. Puzniak

h-index 20 View on Semantic Scholar

We have 2 of 73 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

2024-2025 BNT162b2 KP.2 COVID-19 full season vaccine effectiveness from vaccine registries linked to administrative claims in two states: A cohort study in non-immunocompromised adults.

BNT162b2 provided protection against COVID-19-associated outcomes of ED, UC or hospitalization among non-immunocompromised U.S. adults, including those with UMCs, over the course of the 2024-2025 respiratory virus season, supporting continued vaccine recommendations.

Tara Ahi, K. Andersen, J. Mateus et al. · Vaccine · 0 citations

Jul 2026

KP.2-Adapted BNT162b2 COVID-19 Vaccine Uptake and Effectiveness in Children.

KP.2-adapted BNT162b2 COVID-19 vaccine provided significant protection against emergency department, urgent care, and inpatient encounters for COVID-19 in children.

K. Andersen, Tara Ahi, Maria D. McColgan et al. · Jornal de Pediatria · 0 citations